Treatment of Advanced and Metastatic Solid Tumors With MIL97

Clinical trial NCT04965077 · RECRUITING

Trial details

NCT number: NCT04965077
Sponsor: Beijing Mabworks Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumor

Start date: 2022-01-18
Primary completion: 2025-12-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.